2024
DOI: 10.1039/d4ra05497k
|View full text |Cite
|
Sign up to set email alerts
|

A review of the known MTA-cooperative PRMT5 inhibitors

Mei Hu,
Xiang Chen

Abstract: Protein arginine methyltransferase 5 (PRMT5) represents a novel epigenetic anti-tumour target with significant clinical potential, and has attracted considerable interest from the academic research community and the pharmaceutical industry.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 114 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?